Lisa Mendelson has been a nurse practitioner at the Boston University Amyloidosis Center since 2017. She obtained her nurse practitioner degree from MGH Institute of Health Professions in 2010 and prior to coming to BU worked in private practice cardiology and hepatology in San Mateo, CA. In addition to her clinical practice she participates as a reviewer for multiple peer reviewed journals, is an active board member for the Amyloidosis Research Consortium-Patient Discovery and has authored multiple publications with a focus on amyloidosis awareness. She is the recipient of the BU Medical Group's 2019 clinical excellence award.
Diversity, Equity, Inclusion and Accessibility
Initially I was annoyed at having to write a DEIA statement. As a mid level provider I do not have the power to tailor my practice or career the same as a physician. We are assigned what patients we will see and what research we participate in. Then I realized, I am actually annoyed at myself because it is my, not the institution’s responsibility to be mindful and ever cognizant of diversity, equity, inclusion and accessibility. Growing up I lived with refugee families from all over the world, we housed families while getting them set up with jobs, healthcare and housing. The racism and hurdles these families faced all was horrifying and I vowed to ensure that no matter what I did “when I grow up” I would be part of the solution. My previous employments focused on marginalized populations- home care for elderly, social worker for department of child and family, healthcare for the homeless…My current position does not and that is my fault. So thank you BU for making me write this statement and making me realize I have lost myself over the past few years and become complacent. I vow to do better in the future.
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 15 results.
Gustine JN, Szalat RE, Staron A, Joshi T, Mendelson L, Sloan JM, Sanchorawala V. Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes. Haematologica. 2023 Jun 01; 108(6):1680-1684.View Related Profiles. PMID: 36546447
Mendelson L, Prokaeva T, Lau KHV, Sanchorawala V, McCausland K, Spencer B, Dasari S, McPhail ED, Kaku MC. Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions. Amyloid. 2023 May 04; 1-7.View Related Profiles. PMID: 37140928
Alreshq R, Cozzolino M, Lilleness B, Pipilas A, Mendelson L, Joshi T, Muralidhar V, Guardino E, Berk JL, Siddiqi OK, Gopal DM, Sanchorawala V, Ruberg FL. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Am J Cardiol. 2022 Oct 15; 181:105-112.View Related Profiles. PMID: 36028388; PMCID: PMC9675982; DOI: 10.1016/j.amjcard.2022.06.064;
Fogaren T, Shelton AC, Faller DV, Stull DM, Thuenemann S, Mendelson L. Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses. Clin J Oncol Nurs. 2022 Jul 25; 26(4):421-432. PMID: 35939729
Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles. PMID: 35731907
Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky A, Havasi A. Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis. Kidney Med. 2022 Apr; 4(4):100427.View Related Profiles. PMID: 35342879; PMCID: PMC8942830; DOI: 10.1016/j.xkme.2022.100427;
Schulman A, Connors LH, Weinberg J, Mendelson LM, Joshi T, Shelton AC, Sanchorawala V. Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. Eur J Haematol. 2020 Oct; 105(4):495-501.View Related Profiles. PMID: 32564450; DOI: 10.1111/ejh.13472;
Hwa L, Fogaren T, Faller D, Stuller D, Thuenemann S, Mendelson, L
. L Immunoglobulin Light-chain
Amyloidosis: Clinical Presentations and Diagnostic Approach. Journal of the Advanced Practitioner in Oncology. 2020; 4(11):395-400. View Publication
Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala V. A new era of amyloidosis: the trends at a major US referral centre. Amyloid. 2019 Dec; 26(4):192-196.View Related Profiles. PMID: 31306033
Hwa YL, Fogaren T, Sams A, Faller DV, Stull DM, Thuenemann S, Mendelson L. Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach. J Adv Pract Oncol. 2019 Jul; 10(5):470-481. PMID: 33457060; PMCID: PMC7779572; DOI: 10.6004/jadpro.2019.10.5.5;
Nguyen VP, Rosenberg A, Mendelson LM, Comenzo RL, Varga C, Sanchorawala V. Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis. Amyloid. 2018 Sep; 25(3):156-159.View Related Profiles. PMID: 30032640
Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827.View Related Profiles. PMID: 29933072; PMCID: PMC7553205; DOI: 10.1016/j.bbmt.2018.06.018;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
Faculty excellence award
2019 Boston University Medical Group :
Advanced Practice Provider Excellence
2010 MGH Institute of Health Professions:
Sigma Theta Tau Honor Society
2002 Emmanuel College:
Magna Cum Laude